Harbin Pharmaceutical Group Overview

  • Year Founded
  • 1989

Year Founded

  • Status
  • Public

  • Employees
  • 2,960

Employees

  • Stock Symbol
  • 600829

Stock Symbol

  • Investments
  • 4

  • Share Price
  • $0.78
  • (As of Monday Closing)

Harbin Pharmaceutical Group General Information

Description

HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.

Contact Information

Website
www.hayao.com
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
SHG
Corporate Office
  • Number 109 Xue Fu Road
  • Harbin City, Nangang District 150086
  • China
+86 0451 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Harbin Pharmaceutical Group Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.78 $0.78 $0.70 - $1.44 $455M 580M 3.7M $0.07

Harbin Pharmaceutical Group Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 488,625 654,253 560,969 716,143
Revenue 1,445,292 1,468,573 1,431,589 1,442,639
EBITDA 57,379 65,990 65,429 71,769
Net Income 41,774 41,296 39,272 42,945
Total Assets 1,033,266 1,047,663 1,023,117 1,058,658
Total Debt 162,411 143,778 183,840 208,276
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Harbin Pharmaceutical Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Harbin Pharmaceutical Group‘s full profile, request access.

Request a free trial

Harbin Pharmaceutical Group Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engag
Pharmaceuticals
Harbin City, China
2,960 As of 2023
00000000000

000000

et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullam
000000000000000
Mumbai, India
00 As of 0000
00.000
0&0

000000

is nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
0000 000000000
Seoul, South Korea
0000 As of 0000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Harbin Pharmaceutical Group Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novartis India Corporate Backed or Acquired Mumbai, India 00 00.000 0&0
Daewoong Pharmaceutical Company Corporation Seoul, South Korea 0000 00000000
China Resources Pharmaceutical Group Corporation Hong Kong, Hong Kong 00000 00.000 00000000 00.000
3Sbio Formerly PE-Backed Shenyang, China 0000 00000 00000000 00000
To view Harbin Pharmaceutical Group’s complete competitors history, request access »

Harbin Pharmaceutical Group Executive Team (3)

Name Title Board Seat
Haiying Xu General Manager & Director
Bo Liu Deputy General Manager, Chief Accounting Officer & Director
You’re viewing 2 of 3 executive team members. Get the full list »

Harbin Pharmaceutical Group Board Members (3)

Name Representing Role Since
00000 000 Self Board Member 000 0000
You’re viewing 1 of 3 board members. Get the full list »

Harbin Pharmaceutical Group Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Harbin Pharmaceutical Group Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Harbin Pharmaceutical Group‘s full profile, request access.

Request a free trial

Harbin Pharmaceutical Group Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
General Nutrition Centers 07-Aug-2020 0000000000 00000 Specialty Retail
Chinese Health Products (GNC/Harbin Pharmaceutical Group) 13-Feb-2019 00000 0000 Other Consumer Non-Durables
General Nutrition Centers 13-Feb-2019 0000 00000 Specialty Retail 00000 000
Pfizer(swine vaccine business) 31-May-2010 Merger/Acquisition 0000 Drug Delivery
To view Harbin Pharmaceutical Group’s complete investments and acquisitions history, request access »

Harbin Pharmaceutical Group Subsidiaries (1)

Company Name Industry Location Founded
General Nutrition Centers Specialty Retail Pittsburgh, PA 0000
To view Harbin Pharmaceutical Group’s complete subsidiaries history, request access »

Harbin Pharmaceutical Group FAQs

  • When was Harbin Pharmaceutical Group founded?

    Harbin Pharmaceutical Group was founded in 1989.

  • Where is Harbin Pharmaceutical Group headquartered?

    Harbin Pharmaceutical Group is headquartered in Harbin City, China.

  • What is the size of Harbin Pharmaceutical Group?

    Harbin Pharmaceutical Group has 2,960 total employees.

  • What industry is Harbin Pharmaceutical Group in?

    Harbin Pharmaceutical Group’s primary industry is Pharmaceuticals.

  • Is Harbin Pharmaceutical Group a private or public company?

    Harbin Pharmaceutical Group is a Public company.

  • What is Harbin Pharmaceutical Group’s stock symbol?

    The ticker symbol for Harbin Pharmaceutical Group is 600829.

  • What is the current stock price of Harbin Pharmaceutical Group?

    As of 22-Jul-2024 the stock price of Harbin Pharmaceutical Group is $0.78.

  • What is the current market cap of Harbin Pharmaceutical Group?

    The current market capitalization of Harbin Pharmaceutical Group is $455M.

  • What is Harbin Pharmaceutical Group’s current revenue?

    The trailing twelve month revenue for Harbin Pharmaceutical Group is $1.45B.

  • Who are Harbin Pharmaceutical Group’s competitors?

    Novartis India, Daewoong Pharmaceutical Company, China Resources Pharmaceutical Group, and 3Sbio are competitors of Harbin Pharmaceutical Group.

  • What is Harbin Pharmaceutical Group’s annual earnings per share (EPS)?

    Harbin Pharmaceutical Group’s EPS for 12 months was $0.07.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »